These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Malignant fibrous histiocytoma secondary to allogeneic bone marrow transplantation. Iori AP, Arcese W, Pinto RM, Favre C, Macchia P. Bone Marrow Transplant; 1994 Sep; 14(3):492. PubMed ID: 7994282 [No Abstract] [Full Text] [Related]
3. Secondary malignant fibrous histiocytoma following radiation therapy for carcinoma of the uterine cervix: report of two cases. Ohno T, Sakurai H, Saito Y, Takahashi M, Fukusato T, Mitsuhashi N, Niibe H. Radiat Med; 1997 Sep; 15(4):229-33. PubMed ID: 9311039 [Abstract] [Full Text] [Related]
4. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML. Schleuning M, Günther W, Tischer J, Ledderose G, Kolb HJ. Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194 [Abstract] [Full Text] [Related]
6. Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD). Gmeinhart B, Hinterberger W, Greinix HT, Rabitsch W, Kirnbauer R, Reiter E, Volc-Platzer B. Bone Marrow Transplant; 1999 Jun; 23(11):1197-9. PubMed ID: 10382961 [Abstract] [Full Text] [Related]
7. Malignant fibrous histiocytoma arising in medullary long bone infarcts. A case report. Breen TF, Healy WL. Orthopedics; 1987 Aug; 10(8):1169-73. PubMed ID: 2819837 [Abstract] [Full Text] [Related]
8. [Diagnosis and treatment of primary malignant fibrous histiocytoma of bone]. Wang JH. Zhonghua Wai Ke Za Zhi; 1993 Feb; 31(2):82-4. PubMed ID: 8223011 [Abstract] [Full Text] [Related]
12. Meningioma in long-term survivors after allogeneic bone marrow transplantation. Meignin V, Gluckman E, Gambaraelli D, Devergie A, Ramee MP, Janin A, Socié G. Bone Marrow Transplant; 1998 Oct; 22(7):723-4. PubMed ID: 9818703 [Abstract] [Full Text] [Related]
13. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Saito Y, Uzuka Y, Sakai N, Suzuki S, Toyota T. Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535 [Abstract] [Full Text] [Related]
14. Malignant diseases after allogeneic bone marrow transplantation: an updated overview. Socié G, Henry-Amar M, Devergie A, Esperou-Bourdeau H, Ribaud P, Traineau R, Gluckman E. Nouv Rev Fr Hematol (1978); 1994 Jun; 36 Suppl 1():S75-7. PubMed ID: 8177721 [Abstract] [Full Text] [Related]
15. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation. Bylund KC, Giampoli E, Singh D, Doerr T, Sahasrabudhe D, Liesveld J, Constine LS. Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356 [Abstract] [Full Text] [Related]
17. Tandem high-dose chemotherapy supported by autologous peripheral blood stem-cell transplantation and radiotherapy for recurrent malignant fibrous histiocytoma. Bölke E, Ruf L, Budach W, Reinecke P, Röhrborn A, Pape H, Schwarz A, Schmitt G, Aul C. Wien Klin Wochenschr; 2005 Dec; 117(23-24):833-6. PubMed ID: 16437321 [Abstract] [Full Text] [Related]
19. Late development of a malignant fibrous histiocytoma at the site of a giant cell tumor. Ortiz-Cruz EJ, Quinn RH, Fanburg JC, Rosenberg AE, Mankin HJ. Clin Orthop Relat Res; 1995 Sep; (318):199-204. PubMed ID: 7671517 [Abstract] [Full Text] [Related]
20. [Development of cerebellar astrocytoma in a patient with acute myeloid leukemia 8 years after his second bone marrow transplant]. Matsuo K, Kondoh E, Mitome M, Takeuchi M, Matsue K. Rinsho Ketsueki; 1999 May; 40(5):427-9. PubMed ID: 10390894 [Abstract] [Full Text] [Related] Page: [Next] [New Search]